Novartis International AG / Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease processed and transmitted by Hugin AS.
Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the